AquaBounty Technologies appoints Christine Thompson St.Clare to Board as Non-Executive Director

– USA, MA – AquaBounty Technologies, Inc. (AIM: ABTX), a biotechnology company focused on enhancing productivity in the aquaculture market, is pleased to announce the appointment of  Christine Thompson St.Clare as a Non-Executive Director of the Company with immediate effect. In addition to her appointment to the Board, Ms. St.Clare will be a member of the Company’s Audit Committee.

Christine Thompson St.Clare, aged 63, is a former partner and director at KPMG LLP.  She currently serves as a director for Polymer Group, Inc., a global manufacturer of engineered materials, serving as Chair of the Audit Committee. She is also a member of the Board of Directors of Fibrocell Science, Inc., a publicly-traded life sciences company.  Ms. St.Clare also serves on the Advisory Board of Houlihan Lokey, a global investment bank.  Ms. St.Clare holds a BS in accounting from California State University at Long Beach and has been a CPA since 1977. 

In conjunction with the appointment of Ms. St.Clare, the Company announces that Thomas Barton will be stepping down from the Board.  Mr. Barton joined the Board as one of four Board representatives of Intrexon Corporation, when it took a majority share in the Company, and is departing to allow for Ms. St.Clare to take up one of the four positions.

Richard Clothier, Chairman of AquaBounty, said: “I’d like to thank Tom for his support to the Company during this transition and particularly for his guidance on corporate finance and capital markets.  We welcome Christine to the Board and look forward to her contribution as the Company embarks on this next phase in its development.”

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.